Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Guerbet SA Appoints Ms. Marie-Claire Janailhac-Fritsch as Chairwoman of the Board of Directors


Monday, 30 Sep 2013 11:56am EDT 

Guerbet SA announced that it has appointed Ms. Marie-Claire Janailhac-Fritsch as the Company's Chairwoman of the Board of Directors. Ms. Janailhac-Fritsch will replace Mr. Jean-Jacques Bertrand, who resigned from his post. 

Latest Key Developments in Pharmaceuticals

Company Quote

28.24
0.04 +0.14%
11 Jul 2014